The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Webcast
Get introduced to risk sharing in health care and learn how providers and suppliers can work together to generate financial, operational and clinic
Case Studies
CASE STUDY PARTICIPANTS:
Case Studies
WORK GROUP TITLE:UDI Capture Work GroupCASE STUDY PARTICIPANTS:
Supply Chain Strategies & Solutions Article
Collecting and analyzing data has been a top priority for the healthcare supply chain in recent years.
Supply Chain Strategies & Solutions Article